About me
Stephen "Larry" Mecham, DO, FAPA Past- President
Child and Adolescent Psychiatrist in Phoenix, AZ
Education
- Fellowship: Child and Adolescent Psychiatry Fellowship, Creighton University School of Medicine, Phoenix, AZ
- Residency: Psychiatry Residency, University of Arizona College of Medicine-Phoenix, 2016–2020
- Internship: Information not publicly available.
- Medical School: Doctor of Osteopathic Medicine (DO), Arizona College of Osteopathic Medicine of Midwestern University, 2012–2016
- Undergraduate: Information not publicly available.
Achievements and Publications
- "Top Doc" by PHOENIX magazine in 2019
- Fellow of the American Psychiatric Association 2024
- APS Presidental Service Award 2022-2023
- Factors Contributing to Subjectively Reported Side Effects of Clozapine in Treatment-Resistant Schizophrenia" at the 2018 American Psychiatric Association Annual Meeting
Biography
Professional experience
Dr. Stephen Lawrence Mecham, DO, is a highly respected, board-certified psychiatrist dedicated to providing comprehensive mental health care in Phoenix, Arizona. He earned his Doctor of Osteopathic Medicine degree from the Arizona College of Osteopathic Medicine at Midwestern University, followed by specialized training through a Child and Adolescent Psychiatry Fellowship at Creighton University.
With a deep commitment to improving the lives of his patients, Dr. Mecham specializes in treating a wide range of psychiatric conditions, including seasonal affective disorder, major depression, and bipolar disorder. His expertise spans both adult and adolescent psychiatry, allowing him to offer tailored treatment plans that integrate evidence-based therapies with a compassionate approach.
Dr. Mecham is affiliated with Banner – University Medical Center Phoenix and practices at NOAH Balsz Health Center in Phoenix and Copper Springs in Avondale, Arizona. He accepts multiple insurance plans, ensuring accessible care for his patients.
Beyond his clinical work, Dr. Mecham is a recognized leader in the psychiatric community. He served as President of the Arizona Psychiatric Society, advocating for policies that improve mental health care access and professional development. His dedication to advancing psychiatry has been acknowledged through prestigious honors, including being named a "Top Doc" by PHOENIX magazine in 2019—an award granted by peer selection to physicians demonstrating excellence in their field.
A committed scholar, Dr. Mecham has contributed to psychiatric research, including presenting his work on "Factors Contributing to Subjectively Reported Side Effects of Clozapine in Treatment-Resistant Schizophrenia" at the 2018 American Psychiatric Association Annual Meeting. His research helps shape the understanding and treatment of complex psychiatric disorders.
With a deep commitment to improving the lives of his patients, Dr. Mecham specializes in treating a wide range of psychiatric conditions, including seasonal affective disorder, major depression, and bipolar disorder. His expertise spans both adult and adolescent psychiatry, allowing him to offer tailored treatment plans that integrate evidence-based therapies with a compassionate approach.
Dr. Mecham is affiliated with Banner – University Medical Center Phoenix and practices at NOAH Balsz Health Center in Phoenix and Copper Springs in Avondale, Arizona. He accepts multiple insurance plans, ensuring accessible care for his patients.
Beyond his clinical work, Dr. Mecham is a recognized leader in the psychiatric community. He served as President of the Arizona Psychiatric Society, advocating for policies that improve mental health care access and professional development. His dedication to advancing psychiatry has been acknowledged through prestigious honors, including being named a "Top Doc" by PHOENIX magazine in 2019—an award granted by peer selection to physicians demonstrating excellence in their field.
A committed scholar, Dr. Mecham has contributed to psychiatric research, including presenting his work on "Factors Contributing to Subjectively Reported Side Effects of Clozapine in Treatment-Resistant Schizophrenia" at the 2018 American Psychiatric Association Annual Meeting. His research helps shape the understanding and treatment of complex psychiatric disorders.
Let's create solutions together
Coming Soon!